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Glutathione uptake and protection against oxidative injury in isolated
kidney cells. Analysis with radiotracer and high performance liquid
chromatography techniques showed that glutathione (GSH) is trans-
ported intact into cells primarily of proximal tubule origin. Charac-
teristics of GSH uptake were the same as previously reported for
basal-lateral membrane vesicles, namely, uptake was Nat-dependent,
inhibited by y-glutamylglutamate and/or probenecid, and not inhibited
by cysteinylglycine or the constituent amino acids. Studies with inhib-
itors of y-glutamyltransferase (acivicin) and y-glutamylcysteine synthe-
tase (buthionine sulfoximine) showed that GSH uptake, degradation
and resynthesis are independent processes. The GSH uptake rate with
1 mM GSH was approximately three-fold greater than the GSH syn-
thetic rate with I m amino acids. To examine whethet uptake of GSH
can supplement synthesis to protect against injury, we incubated cells
with a toxic concentration of t-butylhydroperoxide with or without
GSH or its constituent amino acids. Although amino acids provided
significant protection, GSH provided greater protection (cells with
t-butylhydroperoxide plus GSH were not significantly different from
cells alone). This protection by GSH was eliminated by y-
glutamylglutamate or probenecid, indicating that GSH uptake was
required for the protection seen. Protection was also eliminated when
the GSSG reductase/GSH peroxidase system was inhibited by bis-
chloronitrosourea (BCNU), indicating that GSH transport affords pro-
tection by maintaining GSH levels in the cell. Thus, intact GSH is
transported into isolated proximal tubule cells by a Na-dependent
system, and this transported GSH can be used to supplement endoge-
nous synthesis and GSSG reduction to protect cells against oxidative
injury.
Because the kidneys function in toxin and waste elimination,
the epithelium of the renal tubule can be exposed to a variety of
toxic compounds. The epithelial cells of the renal tubule have a
high concentration of glutathione (GSH) [1], a tripeptide in-
volved in detoxication. GSH reacts with electrophilic com-
pounds and serves as a reductant for selenium-dependent and
independent peroxidases [21. Studies with a variety of cell types
have shown that decreases in GSH increase the sensitivity to
oxidative and chemical injury.
Recently, our laboratory has established that isolated cells
from the intestine and lungs are substantially protected against
t-butylhydroperoxide-, menadione-, or paraquat-induced toxic-
ity when incubated with GSH, either at 1 m or at a physio-
logical plasma concentration (20 tM) [3, 4]. For it to be an
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effective cellular protectant, GSH had to be transported into
these cells.
In isolated plasma membrane vesicles from rat kidney cortex,
GSH is taken up by a Nat-dependent, electrogenic mechanism
in the basal-lateral membrane, but is not transported by this
mechanism in brush border membranes [5, 6]. GSSG, y-glu-
tamyiglutamate and a glutathione conjugate were also trans-
ported in basal-lateral membrane vesicles by a Nat-dependent,
electrogenic mechanism, and transport of these compounds was
competitive with GSH transport. Incubations with a fivefold
excess concentration of Cys, Gly, or Cys-Gly did not inhibit
transport while a fivefold excess of Glu gave only 25% inhibi-
tion. Thus, the basal-lateral transport system appears to be
specific for the y-glutamyl moiety and relatively non-specific for
other portions of the GSH molecule. Calculations of the energy
available from the plasma membrane potential and sodium
gradient in the proximal tubule cell indicate that sufficient
energy is available to drive GSH uptake against the substantial
concentration gradient that occurs from the blood plasma to cell
cytosol [6].
An electrogenic GSH transport system has also been de-
scribed in renal brush-border membrane vesicles [7]. This
transporter has characteristics compatible with a role in GSH
efflux from the cell into the tubular lumen, and recent studies [8]
have indicated that kidneys secrete GSH into the lumen. Thus,
current evidence indicates that both uptake and efflux can occur
in the kidney. This transport may be important both in regula-
tion of renal and organismic GSH homeostasis.
In the current study, we examined whether isolated kidney
cells can take up intact GSH. The results show that such
transport does occur and can function to supplement endoge-
nous synthesis of GSH to protect against injury by the oxidant,
t-butylhydroperoxide.
Methods
Glutathione (GSH), glutathione disulfide (GSSG), 1-fluoro-2,
4-dinitrobenzene, collagenase Types I and IV, Percoll, proben-
ecid, HEPES [N-2-hydroxyethylpiperazine-N'-2-ethanesulfon-
ic acid], heparin, and y-L-glutamyl-L-glutamate were pur-
chased from Sigma, St. Louis, Missouri, USA. Ophthalmic acid
was purchased from Bachem (Torrance, California, USA).
Acivicin [L-(aS-5S)-a-amino-3-chloro-4,5-dihydro-5-isoxazole
acetic acid] was from Upjohn Co., Kalamazoo, Michigan,
USA. [Glycine-2-3HJGSH (specific activity, 1.1 Ci/mmol), 14C-
glycine (50.3 mCilmmol) and '4C-Cys-Cys (306 mCi/mmol) were
74
Hagen et a!: GSH uptake andprotection in kidney cells 75
purchased from New England Nuclear, Boston, Massachu-
setts, USA. Carmustine [N,N-bis(2-chloroethyl)-N-nitrosourea;
BCNU] was obtained from the Emory University Hospital. All
other chemicals used were reagent grade.
Male white rats (Sprague-Dawley outbred albino, King Ani-
mal Laboratories, Oregon Wisconsin, USA) weighing between
175 and 250 g were anesthetized by injection of Nembutal (0.1
mI/0. 1 kg) i.p. and killed after cannulation by cutting through
the diaphragm. Isolated kidney cells were obtained by a colla-
genase perfusion technique as previously described [9]. This
preparation contains a mixture of cell types, of which 70 to 80%
are of proximal tubular origin [10]. Cell viability was assessed
by the ability of the cells to exclude 0.2% trypan blue. Initial
viability was 80 to 95%. Cell concentrations were quantified
using a hemacytometer.
Cell viability studies
Isolated cells (106 cells/mI) were suspended in Krebs-Hense-
leit medium (pH 7.4) that was preequilibrated with 95% 02/5%
CO2 and supplemented with 12.5mi HEPES, 7 mti glutamate,
and 5 m glucose. All incubations were performed in a gyrotory
waterbath at 370, except as indicated. In some studies,
glutamyltransferase activity was inhibited by preincubation of
the cell suspension with 0.25 ifiM acivicin [11] for 20 minutes
prior to the start of the experiment. In the viability studies,
agents tested for their ability to protect renal epithelial cells
against t-butylhydroperoxide-mediated cell death (1 m and 20
j.LM GSH, 0.5 mrvi GSSG, 0.5 mivi dithiothreitol [DTF], or 1 mM
each of cysteine, glutamate, and glycine) were added to the cell
suspension 10 minutes prior to addition of 150 /.LM t-butylhy-
droperoxide. When the physiological GSH concentration was
used (20 SM), GSH was added to the cell suspension every 30
minutes throughout the experimental time course to maintain
the concentration. When 50 tM BCNU (in dimethylformamide)
was present, it was added 30 minutes prior to the start of the
experiment. When probenecid (1 mM) and/or y-glutamylgluta-
mate (10 mM) was used, these compounds were added five
minutes prior to addition of GSH.
Glutathione uptake studies
Cells (106 cells/mI) were pretreated for 30 minutes with
acivicin to inhibit y-glutamyltransferase, and the experiments
were initiated by addition of 1 mM 3H-GSH (0.1 mCi/mmol).
Aliquots (0.5 x 10 cells/aliquot) were layered onto 10% Percoll
in Krebs-Henseleit medium in microcentrifuge tubes at the
times indicated. The tubes were centrifuged for 30 seconds, the
supernatants aspirated, and the pellets washed by resuspending
in Krebs-Henseleit medium and recentrifuging for 30 seconds.
After removing the supernatant, the cells were lysed and
protein was precipitated by addition of 150 d of 30% (wt/vol)
trichloroacetic acid. Radioactivity in the supernatant was de-
termined by liquid scintillation counting.
To test for intact GSH transport, cell lysates were derivatized
with 40 mi iodoacetic acid and l-fiuoro-2,4-dinitrobenzene
[1.5% (vol/vol) in absolute ethanol] as described by Reed et al
[12]. The dinitrophenyl derivatives were separated by high
performance liquid chromatography (HPLC) on a 5 xm Ami-
nospheri-5 column (Brownlee Laboratory, Santa Clara, Califor-
nia, USA) and detected at 365 nm. GSH in the lysates was
quantified relative to standards by integration.
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Fig. 1. Uptake of GSH by isolated renal proximal tubule epithelial
cells. Incorporation of 3H-GSH into cells was quantified by scintillation
counting of the cellular extracts. Aliquots were taken at 3, 10, 15, and
30 mm. The initial rate of GSH uptake was 1.1 nmol/106 cells per mm.
Symbols are: (0) Nat; (I), no Nat; (•) cells under anaerobic
conditions. Values are given as mean SE for 4 cell preparations.
Values for Na-free and anaerobic incubations were significantly
different (P < 0.05) from corresponding Na containing and aerobic
incubations at time points indicated by an asterisk.
The dependence of GSH transport on Na was assessed by
use of Nat-free Krebs-Henseleit medium where an equimolar
concentration of choline Cl was substituted for NaCI. The
ability of y-glutamyl compounds to inhibit transport was exam-
ined by preincubation with 10 mrvi yglutamylglutamate in the
cell suspension five minutes prior to 3H-GSH addition. Proben-
ecid (1 mM), a known organic anion transport inhibitor [13] and
inhibitor of GSH transport in basal-lateral membrane vesicles,
was also added to isolated cell suspensions to assess whether
this affected transport.
For anaerobic experiments, cells (1.0 x 106 cells/mI) were
suspended in modified Krebs-Henseleit medium that had been
deoxygenated by bubbling with 100% argon. Oxygen concen-
tration was monitored by an oxygen electrode (Yellow Springs
Instruments, Model 53) and, after the cells became anaerobic, a




To examine GSH uptake in kidney cells, we first treated cells
with acivicin to inhibit y-glutamytransferase to minimize arte-
facts due to GSH breakdown. Acivicin-treated cells (106/ml)
incubated with 1 mi [glycine-2-3H]GSH showed an increase in
radiolabel that approached a steady state after 20 minutes (Fig.
1); the initial rate of transport based upon the specific activity of
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Fig. 2. Analysis of GSH uptake by HPLC. Supernatants from tn-
chloroacetic acid (10%) precipitates of cells were derivatized according
to Reed et at [121. A. Typical HPLC elution profile of DNP-derivatized
cellular extracts is shown (15 mm time point). GSH retention time =
23.3 mm. B. HPLC elution profile of 3H-radiolabel. Eluent from the
HPLC was collected (1 mI/mm per fraction tube) and quantified by
scintillation counting. Greater than 90% of the radiolabel comigrated
with the same retention time as GSH.
GSH content (Fig. 2A) showed that the concentration increased
from 2 to 18 nmoL/106 cells within 30 minutes. Analysis of
radiolabel content at 15 minutes showed that 80% or more of the
radiolabel co-migrated with the GSH peak (Fig. 2B). The rest of
the radiolabel co-migrated with GSH-Cys (up to 15%) or Gly
(up to 5%).
To compare the rate of uptake to GSH synthesis, we deter-
mined the rate of GSH synthesis with 1 mt concentrations of
amino acid precursors containing '4C-cystine or !4Cglycine.
The rate of GSH formation (0.15 to 0.28 nmolIlO6 cells per mm;
Table 1) corresponds with previously reported rates (0.33
nmol/l06 cells per mm) [10], and shows that the rate of uptake
under the conditions of our experiment (1.1 nmol/106 cells per
mm) is greater than the rate of GSH synthesis.
Since the radiolabel of GSH used in the transport studies was
located in the glycine moiety, experiments were performed to
test whether exchange of '4C-Gly with the Gly moiety of GSH
couid account for the radiolabeled GSH that was accumulated
Table 1. Rate ofGSH synthesis in isolated renal proximal tubule
epithelial cells
Conditions
Rate of GSH synthesis
nmo!/106 cells per miii




mM amino acids (14C-Cys)
mM amino acids ('4C-Gly)
mM amino acids C4C-Gly) +
I m GSH
0.15 0.04 0.01 0.001
0.18 0.04 0.04 0.01
0.28 0.06 0.06 0.01
Cells (106/ml) were incubated with amino acids at the indicated
concentration and radiolabeled species. After 15 mm, cell lysates were
derivatized for 1-IPLC. All numbers given are the average SE of 3
experiments.
in the cells. We added 1 m each of amino acid precursors,
including '4C-GIy (0.3 tCi/mo1), in the presence of 1 m cold
GSH and monitored the appearance of radiolabeled GSH by
HPLC. Results show that the rate of appearance of radiolabeled
GSH into cell lysates was 0.28 nmol/l06 cells per minute (Table
1). This corresponds to the rate of synthesis without cold GSH
and is insufficient to account for the rate of radiolabeled GSH
appearance found in the transport studies. In all the studies with
radiolabeled cysteine as the precursor, the inhibitor of GSH
synthesis buthionine sulfoximine (BSO) [14] gave greater than
90% inhibition of GSH synthesis. Thus, these results confirm
that transport of intact GSH is necessary to account for the
radiolabel associated with GSH in the previous experiments.
To determine whether GSH transport occurred in the pres-
ence of y-glutamyltransferase activity, experiments were per-
formed as above (Figs. 1, 2) but without acivicin treatment.
Again HPLC analysis showed that GSH increased over time
and that between 60 and 70% of the radiolabel co-migrated with
the GSH peak. The remaining radioactivity was distributed in
unresolved fractions probably representing glycine, cys-
teinylglycine, and the mixed disulfide of Cys and GSH. No
radiolabeled GSSG was detected. Addition of 1 mtvi BSO, a
concentration that inhibits GSH synthesis by 90%, gave only
30% decrease in the rate of radiolabeled GSH appearance in
cells when cells were incubated with 3H-GSH. From these
results, it is clear that GSH is transported intact by renal
proximal tubule epithelial cells; moreover, GSH transport oc-
curs even in the presence of y-glutamyltransferase activity.
Previous studies with basal-lateral membrane vesicles from
kidney demonstrated that GSH transport is a Na-dependent
and electrogenic process [6]. We examined the Na depen-
dence of GSH transport in isolated cells by suspending them in
a Nat-free Krebs-Henseleit medium. Results show that GSH
transport in the absence of Na is less than 50% of the
Nat-containing controls (Fig. 1). Thus, much of the GSH
tranpsort is Na*dependent. Assuming a volume of 3 1d/l06
cells, uptake occurs from 1 m outside to 6 m inside and has
the characteristics of secondary active transport. Consistent
with this, incubation of cells under anaerobic conditions re-
sulted in nearly complete inhibition of uptake (Fig. 1).
Because the transport of GSH in renal basal-lateral mem-
brane vesicles is inhibited by other y-glutamyl compounds or
probenecid [6], y-glutamylglutamate (10 mM), ophthalmic acid
(10 mM) or probenecid (1 mM) was added along with the
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Fig. 3. -y-Glutamylglutamate inhibits uptake of GSH. Cells (1.0 X
cells/rn!) were pretreated with 10 mi y-glutaniylglutamate 10 mm prior
to addition of the 3H-GSH solution. Aliquots were taken at times
indicated and quantified as in Fig. 1. Symbols represent GSH uptake in
the presence of y-glutamylglutamate. The dashed line represents the
uptake of GSH as shown in Fig. 1. Data are given as the mean sr for
three cell preparations. Values were significantly different (P < 0.05)
from controls (Fig. I) at all time points indicaEed by an asterisk.
Identical results were obtained with 10 m ophthalmic acid. Steady-
state accumulations were slightly higher (about 50% of control values)
with 1 mst probenecid.
rate of uptake was inhibited by about 60% (Fig. 3, Table 2) by
any of these compounds. In other experiments, cells were
incubated with a 10 m solution of Glu, Cys, Gly, or Cys-Gly
in addition to the 3H-GSH solution (Table 2). None of these
compounds inhibited GSH transport substantially, indicating
that the amino acid carriers in the proximal tubule are not
responsible for GSH transport. These results indicate that GSH
is recognized by a transport mechanism that is similar or
identical to that previously described for isolated basal-lateral
membrane vesicles from kidney.
Protection of GSH
Since GSH plays a key role in cellular detoxication mecha-
nisms, we examined whether transported GSH could aid in the
protection of renal proximal tubule cells against chemically
induced oxidative injury. Addition of 150 /LM r-butylhydroper-
oxide to cell suspensions (106 cells/mi) caused a dramatic
decrease in cell viability in two hours (Fig. 4A). While the
mechanism of toxicity has not been studied in the kidney, this
compound is known to cause hepatocellular injury by a process
involving the oxidation of intracellular GSH [15], perturbations
of Ca2 homeostasis 1161, and oxidation of cellular and mito-
chondrial pyridine nucleotides [171. Addition of 1 mrvi GSH
along with 150 LM t-butylhydroperoxide resulted in preserva-
tion of cell viability to values comparable to control incuba-
Substance added N % of Control
Control 4 —
Glutamate 10 msi 3 100
Cysteine 10 mM 3 107
Cysteinylglycine 10 tOM 2 97
Glycine /0 mi 3 89
y-Glutamylglutamate 10 mi 4 40
Ophthalmic Acid 10 mti 4 40
Probenecid 1 mM 4 50
tions. Thus, exogenous GSH substantially protected these cells
against t-butylhydroperoxide-mediated cell death.
To assess whether the physiological concentration in the
plasma [18, 19] could provide protection, cells were incubated
with 150 .tM t-butylhydroperoxide and 20 rM GSH (Fig. 4B).
Although there was a slight decline in viability after two hours,
this was not statistically different (P < 0.05) from controls (Fig.
4B). Therefore, these results show that protection can occur at
a GSH concentration in the physiological range for blood
plasma.
To compare protection by exogenous GSH with that pro-
vided by endogenous GSH synthesis, equimolar concentrations
(1 mM) of cysteine, glutamate, and glycine were added to cell
suspensions, with and without t-butyihydroperoxide. These
amino acids provided significant protection but were less than
half as effective as GSH alone (Fig. 5A).
Preincubation of the cells with 1 m'vi BSO inhibits synthesis
of GSH from the amino acid precursors [14]; this treatment also
provides an approach to determine whether amino acids could
offer any protection to renal proximal tubule cells. Results show
that no statistically significant protection from r-butylhydro-
peroxide occurred with the amino acids when 1 mivi BSO was
included (Fig. SB); the viability of cells declined to 28% after
two hours, as compared to 18% in those cells with only
t-butylhydroperoxide added (Fig. SB).
Studies with basal-lateral membrane vesicles indicated that
GSSG may also be transported into proximal cells, but at a
much slower rate [6]. Therefore, GSSG could conceivably
protect proximal cells if it were transported and then subse-
quently reduced intracellularly. We tested this by addition of
0.5 mM GSSG to cells along with t-butylhydroperoxide. Results
show that GSSG gave a slight protection to proximal cells (Fig.
SB). Thus, although this protection is statistically significant,
the reduced form of GSH is necessary for optimal protection to
occur.
Loss of protection
The above data show that exogenous GSH protects kidney
cells against t-butylhydroperoxide injury; however, because
both GSH and t-butylhydroperoxide are supplied exogenously
to the cells, it is possible that the protection seen may be due to
reaction of GSH with t-butylhydroperoxide in the medium. To
address this possibility, we used probenecid, y-glutamylglutam-
ate, or ophthalmic acid to block GSH uptake [6, present study].
If GSH protection were a consequence of extracellular reac-
10
/
Table 2. The effect of amino acid constituents, y-glutamyl analogs










The controls for these experiments were done in the absence of Glu.
The rate of GSH transport was 1.0 nmol/l06 cells per mm, approximate-
ly equal to the rate in the presence of 7 mi GluGlu.
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Fig. 4. Protection of renal proximal tubule epithelia/ ce/Is from t-
butylhydroperoxide-induced injury by exogenous GSH. A. Cells (1.0 X
106 cells/mi) were suspended in modified Krebs-Henseleit medium and,
where appropriate, 1 mi GSH was added 10 mm prior to the start of the
experiment. t-Butylhydroperoxide (150 sM, final concentration) was
added at the beginning of the experiment. Symbols are: (0) control;(I)
cells + 1 mi GSH; (A) cells + 1 m GSH + 150 sM t-butylhydroper-
oxide; (A) cells + 150 /LM t-butylhydroperoxide. B. Cell suspensions
were treated as above except that 20 /.LM GSH was added. GSH was
added every 30 mm to maintain the extracellular concentration. Ali-
quots were taken at times indicated, and viability was assessed by 0.2%
trypan blue exclusion. Symbols are: (0) cells + 20 M GSH; (S) cells
+ 20 M GSH + 150 /LM t-butylhydroperoxide; (A) cells + 150 sM
t-butylhydroperoxide. Averages of at least 4 experiments SE are
given. Values for incubation with t-butylhydroperoxide were signifi-
cantly different (P < 0.05) from control and t-butylhydroperoxide +
GSH as indicated by an asterisk.
tion, protection would still be seen. However, if protection
were due to transport of GSH by the cells, then protection
would be lost. Cells were incubated with y-glutamylglutamate
Amino Acids Amino Acids Amino Acids Amino Acids




Fig. 5. Effect of amino acid constituents of GSH or GSSG on protec-
tion renal proximal epithelial cells from t-butylhydroperoxide-induced
injury. A. I m concentrations of glutamate, cysteine, and glycine were
added to cell suspensions 10 mm prior to addition of 150 j.M t-
butylhydroperoxide and viability was assessed by trypan blue exclu-
sion. To test whether amino acids themselves could offer any protec-
tion, 1 msi BSO was added to some incubations to inhibit GSH
synthesis. B. Cell suspensions were treated as in Fig. 3 except that 0.5
mM GSSG was added instead of reduced GSH. Symbols are: , 30 mm;, 60 mm; VA, 120 mm. Mean SE for 3 preparations are given.
Statistical significance (P < 0.05) is indicated by an asterisk.
and the organic anion transport inhibitor, probenecid, either in
separate incubations or together. Results show that protection
was lost in cell suspensions with the inhibitors (Fig. 6), but the
inhibitors alone did not cause loss of cell viability. Thus, GSH
protection of isolated renal cells does not appear to be a
consequence of extracellular reaction of GSH with t-butylhy-
droperoxide but requires that GSH is transported to exert its
protective effects.
To examine whether an intact GSH peroxidase/GSSG reduc-
tase system is required for the protection seen by exogenous
GSH, cells were treated with BCNU at a concentration that
inhibits GSSG reductase but has little effect on cell viability.
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Fig. 6. Exogenous GSH fails to provide protection of proximal tubule
epit he/ia! cells when cells are pretreated with inhibitors of GSH
transport. To appropriate cell suspensions, 10 mM y-glutylglutamate, I
mM probenecid, or both were added 5 mm prior to addition of GSH and
the experiment was conducted as in Fig. 3. Symbols are: (U) cells + I
mM GSH + 10 mM y-glutamylglutamate + 1 mri probenecid; (0) cells
+ 1 mi GSH + tO mri y-glutamylglutamate; (U) cells + 1 mrvt GSH +
y-glutamylglutamate + 1 mr's probenecid + 150 /.6M t-butylhydroper-
oxide; (•) cells + 1 mai GSH + y-glutamylglutamate + 150 /.tM
t-butylhydroperoxide. Mean SE for 3 cell preparations are given.
Values of cells + GSH + y-glutamylglutamate + t-butylhydroperoxide
are not significantly different (P < 0.05) from cells with t-butylhydro-
peroxide alone, but each indicated by an asterisk is significantly
different (P < 0.05) from controls or cells + t-butylhydroperoxide +
GSH.
against t-butylhydroperoxide-induced damage (Fig. 7). BCNU
pretreatment also caused a further loss in viability of those cells
treated with t-butylhydroperoxide without GSH and caused a
small (statistically significant) loss in control cell viability.
Thus, exogenous GSH protects renal epithelial cells by a
mechanism involving uptake of intact GSH and function of the
GSSG reductase/GSH peroxidase system.
Discussion
Previous studies have shown that GSH efflux occurs from the
liver into the blood [20, 21] and efflux can be enhanced by
certain hormones [221, Since this discovery, many investiga-
tions have centered on the physiological importance of plasma-
derived GSH. It is known that the kidney is the major organ for
GSH and GSH-S conjugate clearance from the plasma [23],
with as much as 80% of plasma GSH turnover occurring in the
kidney. GSH degradation was once thought to solely account
for this turnover, due to an abundance of y-glutamyltransferase
found in the brush border of renal proximal tubule epithelial
cells [24, 25]. However, glomerular filtration alone cannot
account for all the GSH extracted because only about 25% of
the blood volume is filtered. Rankin and Curthoys [26] and
Ormstad, Jones and Orrenius [10] suggested the possibility that
a mechanism for GSH transport existed. Subsequent studies
Fig. 7. Effect of BCNU (50 M) on GSH-dependent protection against
1-butylhydroperoxide-induced cell death. BCNU was added to acivicin-
treated cells (106 cells/mI) 20 mm prior to addition of 1 ms GSH. The
experiment was then carried out as in Fig. 4. Symbols are: (0) cells +
1 mi GSH; () cells + 50 /LM BCNU; ( cells + 1 mi GSH + 50 rM
BCNU; (LI) cells + 1 mat GSH + 150 ILM t-butylhydroperoxide; (•)
cells + 150 LM t-butylhydroperoxide; (U) cells + 150 M t-butylhydro-
peroxide + 1 mat GSH + 50 M BCNU; (A) cells + 150 rM t-
butylhydroperoxide + 50 pi BCNU. Time points represented by
closed symbols were significantly different (P < 0.05) from their
respective controls (open circles).
demonstrated that a Nat-dependent, electrogenic, carrier-me-
diated GSH transport mechanism exists in basal-lateral mem-
brane vesicles of the kidney [5, 6]. This transporter also
accounts for the uptake of the GSH-S conjugate, S-(l,2-dichlo-
rovinyl)GSH [27], thus providing the basis for a secretory
mechanism for GSH-S conjugate clearance from the kidney.
The current study gives evidence that intact GSH is transported
into isolated kidney epithelial cells. Moreover, transport of
intact GSH was demonstrated both in the presence of y-
glutamyltransferase or when activity was inhibited with acivi-
cm. The uptake is Nat-dependent and is inhibited by the same
compounds that inhibit uptake in the basal-lateral vesicles.
Thus, transport occurs concomitantly with hydrolysis. While
the extent of direct uptake of GSH by this system in vivo
remains a matter of speculation, the current results indicate that
GSH transport can provide a mechanism to supplement endog-
enous detoxication systems to protect against chemical and
oxidative injury. This process is likely to occur in vivo at
plasma concentrations of GSH because 20 xM GSH also
provided significant protection against t-butylhydroperoxide
injury.
The cell preparation used for these studies has been well
characterized and contains approximately 70 to 80% proximal
tubule epithelial cells [9, 10]. The extent to which different cell
types of the kidney transport GSH is not known, but the
quantitative aspects both of the uptake and the viability studies
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cells. The observation that the amino acid precursors of GSH
provided little direct protection of cells against oxidative injury
indicates that the amino acids themselves and/or that GSH
synthesis do not provide the extent of protection that GSH
uptake provides. This finding is similar to that observed with
enterocytes [3] but different from the results obtained with
alveolar type II cells, which showed that the amino acids
provide protection equivalent to that seen with GSH [4].
The properties of GSH transport in kidney are identical to
those in isolated enterocytes [3], and pulmonary alveolar type II
cells [4]. It is significant that these cell types, which are
substantially protected against oxidative injury by transported
GSH, are all epithelial cells located in areas that are readily
exposed to oxidative or xenobiotic injury. Hepatic-derived
GSH in the plasma may thus provide a means to supplement
intracellular GSH pools that may become depleted during
chemical or oxidative injury. Oxidants such as redox cycling
compounds (paraquat or menadione) or peroxides cause a rapid
depletion of intracellular GSH pools [28]. Because GSH is a
cosubstrate for both GSH S-transferases and GSH peroxidases,
the depletion of GSH limits their activities, allowing radical
producing peroxides or electrophiles to react with cellular
macromolecules. Also, GSH is involved in maintaining the
intracellular thiol/disulfide ratio that is vital for function of a
variety of enzymes [291. Depletion of GSH leads to alterations
in this ratio and can thereby contribute to altered cellular
function. Our viability studies using BCNU indicate that GSH
transport protects cells by maintaining reduced GSH pools and
allowing the GSH-dependent detoxication systems to continue
to function. Therefore, GSH transport may be a general mech-
anism to maintain intracellular GSH pools in certain epithelial
cells under conditions where GSH levels would otherwise be
depleted.
Inoue and Morino [7] have recently found that a GSH
transport mechanism exists in brush border vesicles of kidney
cells. The electrogenic characteristics of this system are con-
sistent with a role in efflux of GSH from cells into the tubular
lumen. Furthermore, recent work by Scott and Curthoys has
provided evidence that GSH efflux occurs from renal epithelial
cells into the tubular lumen [8]. These authors speculate that
GSH effiux may serve as a mechanism to bring y-glutamyltrans-
ferase at the brush border in contact with its substrate, thereby
functioning in GSH turnover. This transcellular transport of
GSH may also be a way to provide OSH to the lumen to
conjugate reactive species that might otherwise be concentrated
in and toxic to the urinary tract.
Finally, this study provides a rationale for the possible use of
GSH as a direct therapeutic agent to protect against ischemia
and reperfusion injury, radiation damage, chemical toxicity, or
chemical-induced carcinogenesis in the renal epithelium. Paller
[30] found that infusion of GSH increased the cortical content of
GSH and protected against renal dysfunction due to ischemia.
Other studies in our laboratory have shown that GSH is
transported intact from the lumen to the portal circulation in
isolated perfused rat small intestine [31]. These results indicate
that GSH may be taken up intact from the diet, providing a
means by which GSH may be therapeutically administered to
augment plasma GSH concentrations. This may be significant in
those pathological conditions where hepatic GSH efflux is
impaired, such as cirrhosis [32], under conditions of oxidative
stress (02 therapy in newborns) [33] or in conditions where a
decline in GSH is thought to allow deleterious oxidative pro-
cesses (cataract formation in the lens) [34]. Clinical studies will
be needed to assess any therapeutic benefit of GSH.
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